Cooperative binding of AP 1 and TEAD4 modulates the balance between vascular smooth muscle and hemogenic cell fate
The transmission of extracellular signals into the nucleus involves inducible transcription factors, but how different signalling pathways act in a cell type specific fashion is poorly understood. Here, we studied the regulatory role of the AP 1 transcription factor family in blood development using embryonic stem cell differentiation coupled with genome wide transcription factor binding and gene expression analyses. AP 1 factors respond to MAP kinase signalling and comprise dimers of FOS, ATF and JUN proteins. To examine genes regulated by AP 1 and to examine how it interacts with other inducible transcription factors, we abrogated its global DNA binding activity using a dominant negative FOS peptide. We show that FOS and JUN bind to and activate a specific set of vascular genes and that AP 1 inhibition shifts the balance between smooth muscle and hematopoietic differentiation towards blood. Furthermore, AP 1 is required for de novo binding of TEAD4, a transcription factor connected to Hippo signalling. Our bottom up approach demonstrates that AP 1 and TEAD4 associated cis regulatory elements form hubs for multiple signalling responsive transcription factors and define the cistrome that regulates vascular and hematopoietic development by extrinsic signals. Highlighted article: AP 1 activates the expression of vascular genes in hemogenic endothelial cells and is required for de novo binding of the Hippo signaling transcription factor TEAD4.
Development